Hardman Johnston Global Advisors LLC Nevro Corp Transaction History

Hardman Johnston Global Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 18, 2018	SELL	$44.22 - $75.47 $4.23 Million - $7.21 Million	-95,560 Closed	0 $0
Q2 2018 Jul 18, 2018	SELL	$72.38 - $92.5 $364,071 - $465,275	-5,030 Reduced 5.0%	95,560 $7.63 Million
Q1 2018 Apr 30, 2018	BUY	$69.46 - $88.57 $23,616 - $30,113	340 Added 0.34%	100,590 $8.72 Million
Q4 2017 Jan 26, 2018	BUY	$65.94 - $93.31 $46,817 - $66,250	710 Added 0.71%	100,250 $6.92 Million
Q3 2017 Oct 30, 2017	BUY	$80.87 - $91.08 $84,913 - $95,634	1,050 Added 1.07%	99,540 $9.05 Million
Q2 2017 Aug 14, 2017	BUY	N/A	98,490	98,490 $7.33 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $160M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Hardman Johnston Global Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Hardman Johnston Global Advisors LLC with notifications on news.